Cite this article
-
APA : Adnan, M., Saghir, S., & Ahmed, E. (2024). Evaluating Poly-Pharmacy and Drug Interactions in Cardiovascular Treatment: A Call for Vigilant Medication Management. Global Pharmaceutical Sciences Review, IX(II), 1-8. https://doi.org/10.31703/gpsr.2024(IX-II).01
-
CHICAGO : Adnan, Muhammad, Savera Saghir, and Ejaz Ahmed. 2024. "Evaluating Poly-Pharmacy and Drug Interactions in Cardiovascular Treatment: A Call for Vigilant Medication Management." Global Pharmaceutical Sciences Review, IX (II): 1-8 doi: 10.31703/gpsr.2024(IX-II).01
-
HARVARD : ADNAN, M., SAGHIR, S. & AHMED, E. 2024. Evaluating Poly-Pharmacy and Drug Interactions in Cardiovascular Treatment: A Call for Vigilant Medication Management. Global Pharmaceutical Sciences Review, IX, 1-8.
-
MHRA : Adnan, Muhammad, Savera Saghir, and Ejaz Ahmed. 2024. "Evaluating Poly-Pharmacy and Drug Interactions in Cardiovascular Treatment: A Call for Vigilant Medication Management." Global Pharmaceutical Sciences Review, IX: 1-8
-
MLA : Adnan, Muhammad, Savera Saghir, and Ejaz Ahmed. "Evaluating Poly-Pharmacy and Drug Interactions in Cardiovascular Treatment: A Call for Vigilant Medication Management." Global Pharmaceutical Sciences Review, IX.II (2024): 1-8 Print.
-
OXFORD : Adnan, Muhammad, Saghir, Savera, and Ahmed, Ejaz (2024), "Evaluating Poly-Pharmacy and Drug Interactions in Cardiovascular Treatment: A Call for Vigilant Medication Management", Global Pharmaceutical Sciences Review, IX (II), 1-8
-
TURABIAN : Adnan, Muhammad, Savera Saghir, and Ejaz Ahmed. "Evaluating Poly-Pharmacy and Drug Interactions in Cardiovascular Treatment: A Call for Vigilant Medication Management." Global Pharmaceutical Sciences Review IX, no. II (2024): 1-8. https://doi.org/10.31703/gpsr.2024(IX-II).01